Jonathan A. Pachter

Person

Setauket, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Neutralizing human anti-IGFR antibody
- Patent number 8,173,779
- Issue date May 8, 2012
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-IGFR1 antibody therapeutic combinations
- Patent number 8,017,735
- Issue date Sep 13, 2011
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of EMT induction in tumor cells by anti-cancer agents
- Patent number 7,998,688
- Issue date Aug 16, 2011
- OSI Pharmaceuticals, LLC
- Salam A. Shaaban
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing human anti-IGFR antibody
- Patent number 7,851,181
- Issue date Dec 14, 2010
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing human anti-IGFR antibody
- Patent number 7,847,068
- Issue date Dec 7, 2010
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers for pre-selection of patients for anti-IGF1R therapy
- Patent number 7,811,562
- Issue date Oct 12, 2010
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
p53 modulators
- Patent number 7,790,474
- Issue date Sep 7, 2010
- Schering Corporation
- Bimalendu Dasmahapatra
- G01 - MEASURING TESTING
Information Patent Grant
Neutralizing human anti-IGFR antibody
- Patent number 7,667,021
- Issue date Feb 23, 2010
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...
- Patent number 7,485,645
- Issue date Feb 3, 2009
- Schering Corporation
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...
- Patent number 7,432,268
- Issue date Oct 7, 2008
- Schering Corporation
- Timothy Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...
- Patent number 7,271,175
- Issue date Sep 18, 2007
- Schering Corporation
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing human anti-IGFR antibody
- Patent number 7,217,796
- Issue date May 15, 2007
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatme...
- Patent number 7,138,396
- Issue date Nov 21, 2006
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatme...
- Patent number 7,053,091
- Issue date May 30, 2006
- Schering Corporation
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...
- Patent number 6,903,102
- Issue date Jun 7, 2005
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating androgen-dependent disorders
- Patent number 6,710,037
- Issue date Mar 23, 2004
- Schering Corporation
- Lynn Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of neurokinin receptor antagonists to treat androgen-dependent...
- Patent number 6,569,872
- Issue date May 27, 2003
- Schering Corporation
- Michael W. Leach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydro-ethano-indeno-pyridines
- Patent number 5,461,057
- Issue date Oct 24, 1995
- Schering Corporation
- Joel G. Berger
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Methods and Compositions for Treating or Preventing Cancer
- Publication number 20150093398
- Publication date Apr 2, 2015
- MERCK SHARP & DOHME CORP.
- YAOLIN WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZING HUMAN ANTI-IGFR ANTIBODY
- Publication number 20110060130
- Publication date Mar 10, 2011
- YAN WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IGF1R
- Publication number 20110014117
- Publication date Jan 20, 2011
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of EMT induction in tumor cells by anti-cancer agents
- Publication number 20090286850
- Publication date Nov 19, 2009
- Salam A. Shaaban
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZING HUMAN ANTI-IGFR ANTIBODY
- Publication number 20080014197
- Publication date Jan 17, 2008
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREAT...
- Publication number 20080004248
- Publication date Jan 3, 2008
- Schering Corporation
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neutralizing human anti-IGFR antibody
- Publication number 20070059241
- Publication date Mar 15, 2007
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neutralizing human anti-IGFR antibody
- Publication number 20070059305
- Publication date Mar 15, 2007
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and compositions for treating or preventing cancer
- Publication number 20060233810
- Publication date Oct 19, 2006
- Yaolin Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Biomarkers for pre-selection of patients for anti-IGF1R therapy
- Publication number 20060140960
- Publication date Jun 29, 2006
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treat...
- Publication number 20060142338
- Publication date Jun 29, 2006
- Schering Corporation
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...
- Publication number 20060069103
- Publication date Mar 30, 2006
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...
- Publication number 20060014755
- Publication date Jan 19, 2006
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-IGFR antibody therapeutic combinations
- Publication number 20050136063
- Publication date Jun 23, 2005
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040235908
- Publication date Nov 25, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...
- Publication number 20040138226
- Publication date Jul 15, 2004
- Schering Corporation
- Timothy J. Guzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...
- Publication number 20040132736
- Publication date Jul 8, 2004
- Schering Corporation
- Timothy J. Guzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neutralizing human anti-IGFR antibody
- Publication number 20040018191
- Publication date Jan 29, 2004
- Schering Corporation
- Yan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine recepto...
- Publication number 20030204085
- Publication date Oct 30, 2003
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor...
- Publication number 20030097004
- Publication date May 22, 2003
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of neurokinin receptor antagonists to treat androgen-dependent...
- Publication number 20030092602
- Publication date May 15, 2003
- Schering Corporation
- Michael W. Leach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treating androgen-dependent disorders
- Publication number 20020165195
- Publication date Nov 7, 2002
- Schering Corporation
- Lynn Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Jonathan A. Pachter

Person

Patents Grantslast 30 patents

Neutralizing human anti-IGFR antibody

Anti-IGFR1 antibody therapeutic combinations

Inhibition of EMT induction in tumor cells by anti-cancer agents

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

Biomarkers for pre-selection of patients for anti-IGF1R therapy

p53 modulators

Neutralizing human anti-IGFR antibody

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...

Neutralizing human anti-IGFR antibody

17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatme...

17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatme...

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatmen...

Method of treating androgen-dependent disorders

Use of neurokinin receptor antagonists to treat androgen-dependent...

Hydro-ethano-indeno-pyridines

Patents Applicationslast 30 patents

Methods and Compositions for Treating or Preventing Cancer

NEUTRALIZING HUMAN ANTI-IGFR ANTIBODY

ANTI-IGF1R

Inhibition of EMT induction in tumor cells by anti-cancer agents

NEUTRALIZING HUMAN ANTI-IGFR ANTIBODY

17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREAT...

Neutralizing human anti-IGFR antibody

Neutralizing human anti-IGFR antibody

Methods and compositions for treating or preventing cancer

Biomarkers for pre-selection of patients for anti-IGF1R therapy

17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treat...

17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...

17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...

Anti-IGFR antibody therapeutic combinations

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...

17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the trea...

Neutralizing human anti-IGFR antibody

3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine recepto...

3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor...

Use of neurokinin receptor antagonists to treat androgen-dependent...

Method of treating androgen-dependent disorders